PESCIA, CARLO
PESCIA, CARLO
Universita' degli Studi di MILANO
The molecular landscape of myeloproliferative neoplasms associated with splanchnic vein thrombosis: Current perspective
2024 C. Pescia, G. Lopez, D. Cattaneo, C. Bucelli, U. Gianelli, A. Iurlo
The unexpected guest: Cytotoxic, pseudolymphoma-like reaction at the site of primary cutaneous follicle centre B-cell lymphoma in a patient receiving secukinumab for psoriasis
2024 C. Pescia, G. Pini, S. Tabano, E. Berti, S. Alberti Violetti, G.A. Croci
The Evolving Role of Genomic Testing in Early Breast Cancer: Implications for Diagnosis, Prognosis, and Therapy
2024 K. Venetis, C. Pescia, G. Cursano, C. Frascarelli, E. Mane, E. De Camilli, E. Munzone, S. Dellapasqua, C. Criscitiello, G. Curigliano, E. Guerini Rocco, N. Fusco
Thymic Epithelial Tumors: An Evolving Field
2023 E. Kuhn, C. Pescia, P. Mendogni, M. Nosotti, S. Ferrero
Granular cell tumor of the neurohypophysis presenting as a third ventricle mass
2023 G. Lopez, C. Pescia, C. Galli, M. Bramerio, A. Tosoni, M. Nebuloni, M. Ferrara, G. Bertani, L. Caschera, F.M. Triulzi, M. Locatelli, S. Tabano, G.A. Croci
Wait and see: a case of EBV + cutaneous extranodal NK/T-type lymphoma with indolent behaviour
2023 I.F. Aromolo, C. Pescia, D. Simeoli, S.A. Violetti, V. Ferla, F.G. Rossi, G.A. Croci
Advances in Early Breast Cancer Risk Profiling: From Histopathology to Molecular Technologies
2023 C. Pescia, E. Guerini-Rocco, G. Viale, N. Fusco
TIGIT in Lung Cancer: Potential Theranostic Implications
2023 C. Pescia, G. Pini, E. Olmeda, S. Ferrero, G. Lopez
A Rare Case of Urinary Bladder Hamartoma Clinically Mimicking an Urothelial Carcinoma: A Case Report and Review of the Literature
2023 C. Pescia, G. Pini, G. Lopez, M. Malfatto, G. Brescia, S. Tabano, A. Del Gobbo
Fibroblastic/cytokeratin-positive interstitial reticular cell tumor of the spleen with indolent behavior: a case report with review of the literature.
2022 C. Pescia, G. Lopez, U. Gianelli, G. Croci
Lymphocytic infiltrate and p53 protein expression as predictive markers of response and outcome in myelodysplastic syndromes treated with azacitidine
2021 C. Pescia, F. Boggio, G.A. Croci, R. Cassin, M. Barella, L. Pettine, G. Reda, E. Sabattini, C. Finelli, U. Gianelli
Double expressor and double/triple hit status among primary cutaneous diffuse large B-cell lymphoma: a comparison between leg type and not otherwise specified subtypes
2021 M. Lucioni, C. Pescia, A. Bonometti, S. Fraticelli, C. Moltrasio, A. Ramponi, R. Riboni, S. Roccio, G. Ferrario, L. Arcaini, G. Goteri, E. Berti, M. Paulli